Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04172597
Title A Study of Poziotinib in Patients With EGFR or HER2 Activating Mutations in Advanced Malignancies
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Spectrum Pharmaceuticals, Inc
Indications

Advanced Solid Tumor

breast cancer

colorectal cancer

high grade glioma

Therapies

Poziotinib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Pacific Shores Medical Group Long Beach California 90813 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field